论文信息 - Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignancies - 字舞流文

Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignancies

A. Jimeno | M. Hidalgo | M. Borad | G. Weiss | M. Ciomei | F. Fiorentini | R. Tibes | D. V. Hoff | D. Laheru | R. Ramanathan | G. Jameson | M. A. Pacciarini | J. D. Isaacs | Angela Scaburri | Lisa Blaydorn | D. Hoff